Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Dala Vård & Vaccin AB
AB
Active
Org 5590076609
Stationsgatan 11, 784 33
Borlänge
General medical practice activities
· NACE 8621
Est. 2015
5-9 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
Dala Vård & Vaccin AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
4M
8M
12M
16M
7M
2021
7M
2022
13M
2023
14M
2024
11M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
1M
2021
0M
2022
2M
2023
1M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
7 005
7 444
12 582
14 324
11 095
Staff expenses
—
−2 681
−3 512
−4 135
−4 167
EBITDA
816
378
2 176
1 145
279
Depreciation & amort.
−84
−86
−82
−90
−93
EBIT
732
292
2 094
1 055
186
Net financials
−3
—
2
56
16
Profit before tax
729
292
1 596
831
202
Tax
−160
−69
−332
−177
−50
Net profit
569
223
1 264
654
152
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
2 262
1 550
3 429
3 073
2 689
Equity
1 596
419
1 393
798
949
Long-term debt
0
—
—
—
—
Short-term debt
667
1 131
1 535
1 495
959
Total debt
667
1 131
1 535
1 495
959
Financial ratios
5-year trend
EBITDA margin
2.5%
This company
15.8%
Market median
-84% vs market
2021
2025
Equity ratio
35.3%
This company
38.2%
Market median
+8% vs market
2021
2025
Return on equity
16.0%
This company
18.4%
Market median
+13% vs market
2021
2025
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
2021
2025
Asset turnover
4.13×
This company
1.12×
Market median
+269% vs market
2021
2025
Debt / equity
1.83×
This company
0.62×
Market median
-195% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
More on Dala Vård & Vaccin AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
